share_log

HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $110 Price Target

Benzinga ·  Nov 20 23:01  · Ratings

HC Wainwright & Co. analyst Patrick Trucchio reiterates Vir Biotechnology (NASDAQ:VIR) with a Buy and maintains $110 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment